Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer
Raphaël Jorand, Sunetra Biswas, Devin L. Wakefield, et al.
Molecular Biology of the Cell (2016) Vol. 27, Iss. 22, pp. 3659-3672
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Single molecule characterization of individual extracellular vesicles from pancreatic cancer
Kathleen M. Lennon, Devin L. Wakefield, Adam L. Maddox, et al.
Journal of Extracellular Vesicles (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 81
Endogenous Opiates and Behavior: 2016
Richard J. Bodnar
Peptides (2018) Vol. 101, pp. 167-212
Closed Access | Times Cited: 60
The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target
D.T. Chen, Jia-Hao Pan, Y.H. Chen, et al.
British Journal of Anaesthesia (2018) Vol. 122, Iss. 6, pp. e157-e167
Open Access | Times Cited: 57
Structure and Function of Somatostatin and Its Receptors in Endocrinology
Bo Zhang, Xue Li, Zhe Wu
Endocrine Reviews (2024) Vol. 46, Iss. 1, pp. 26-42
Open Access | Times Cited: 4
Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
Müzeyyen Ugur, Lyes Derouiche, Dominique Massotte
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 36
Single molecule localization microscopy coupled with touch preparation for the quantification of trastuzumab-bound HER2
Steven J. Tobin, Devin L. Wakefield, Veronica Jones, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 35
Opioid System and Epithelial–Mesenchymal Transition
Marzena Łazarczyk, Dominik Skiba, Michel‐Edwar Mickael, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 120-120
Open Access
A Platform To Enhance Quantitative Single Molecule Localization Microscopy
Ottavia Golfetto, Devin L. Wakefield, Eliedonna E. Cacao, et al.
Journal of the American Chemical Society (2018) Vol. 140, Iss. 40, pp. 12785-12797
Open Access | Times Cited: 29
Impact of Pain, Opioids, and the Mu-opioid Receptor on Progression and Survival in Patients With Newly Diagnosed Stage IV Pancreatic Cancer
Grant Steele, Arkadiusz Z. Dudek, Grace Gilmore, et al.
American Journal of Clinical Oncology (2020) Vol. 43, Iss. 8, pp. 591-597
Closed Access | Times Cited: 26
Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer
Adam L. Maddox, Matthew Brehove, Kiarash Rahmani Eliato, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2795-2795
Open Access | Times Cited: 13
Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities
Marion Gaborit, Dominique Massotte
British Journal of Pharmacology (2021) Vol. 180, Iss. 7, pp. 994-1013
Open Access | Times Cited: 16
Solid Tumor Opioid Receptor Expression and Oncologic Outcomes: Analysis of the Cancer Genome Atlas and Genotype Tissue Expression Project
Amparo Belltall, S. Zúñiga, Iris Garrido‐Cano, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy
Marianna Ciwun, Anna Tankiewicz‐Kwedlo, Dariusz Pawlak
Cancers (2024) Vol. 16, Iss. 6, pp. 1240-1240
Open Access | Times Cited: 2
Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction?
Amparo Belltall, Guido Mazzinari, Óscar Díaz‐Cambronero, et al.
Current Oncology Reports (2022) Vol. 24, Iss. 10, pp. 1337-1349
Open Access | Times Cited: 11
Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study
Mahdi Sheikh, Sahar Masoudi, Razieh Bakhshandeh, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0243511-e0243511
Open Access | Times Cited: 14
Targeting the mu-Opioid Receptor for Cancer Treatment
Hao Zhang, Di Zhou, Jiahui Gu, et al.
Current Oncology Reports (2021) Vol. 23, Iss. 10
Closed Access | Times Cited: 12
Characterization of Epithelial–Mesenchymal and Neuroendocrine Differentiation States in Pancreatic and Small Cell Ovarian Tumor Cells and Their Modulation by TGF-β1 and BMP-7
Hendrik Ungefroren, Juliane von der Ohe, Rüdiger Braun, et al.
Cells (2024) Vol. 13, Iss. 23, pp. 2010-2010
Open Access | Times Cited: 1
A Biomarker-Based Characterisation of EMT and Neuroendocrine Differentiation States in Pancreatic and Small Cell Hypercalcemic Ovarian Tumor Cells and Their Modulation by Transforming Growth Factor-β and Bone Morphogenetic Protein-7
Hendrik Ungefroren, Juliane von der Ohe, Rüdiger Braun, et al.
(2024)
Open Access | Times Cited: 1
Single-molecule detection of transient dimerization of opioid receptors 2: Heterodimer blockage reduces morphine tolerance
Peng Zhou, Rinshi S. Kasai, Wakako Fujita, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Utilizing Peptide Ligand GPCRs to Image and Treat Pancreatic Cancer
Gail L. Matters, John F. Harms
Biomedicines (2018) Vol. 6, Iss. 2, pp. 65-65
Open Access | Times Cited: 11
Ethanol and Naltrexone Have Distinct Effects on the Lateral Nano-organization of Mu and Kappa Opioid Receptors in the Plasma Membrane
Steven J. Tobin, Devin L. Wakefield, Lars Terenius, et al.
ACS Chemical Neuroscience (2018) Vol. 10, Iss. 1, pp. 667-676
Open Access | Times Cited: 10
Non-Peptide Opioids Differ in Effects on Mu-Opioid (MOP) and Serotonin 1A (5-HT1A) Receptors Heterodimerization and Cellular Effectors (Ca2+, ERK1/2 and p38) Activation
Vlad Radoi, Gerd Jakobsson, Vinko Palada, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2350-2350
Open Access | Times Cited: 6
Opioid Receptor Expression in Colorectal Cancer: A Nested Matched Case-Control Study
Amparo Belltall, Guido Mazzinari, Iris Garrido‐Cano, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Management of Pancreatic Cancer and Its Microenvironment: Potential Impact of Nano-Targeting
Nardeen Perko, Shaker A. Mousa
Cancers (2022) Vol. 14, Iss. 12, pp. 2879-2879
Open Access | Times Cited: 6
Characterizing Binding Interactions That Are Essential for Selective Transport through the Nuclear Pore Complex
Kathleen M. Lennon, Mohammad Soheilypour, Mohaddeseh Peyro, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10898-10898
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top